NACMIAS, BENEDETTA
 Distribuzione geografica
Continente #
NA - Nord America 26.899
EU - Europa 14.937
AS - Asia 12.944
SA - Sud America 1.815
AF - Africa 335
OC - Oceania 211
Continente sconosciuto - Info sul continente non disponibili 6
Totale 57.147
Nazione #
US - Stati Uniti d'America 26.608
RU - Federazione Russa 5.943
SG - Singapore 3.769
CN - Cina 3.336
PL - Polonia 2.260
HK - Hong Kong 1.897
IT - Italia 1.553
BR - Brasile 1.453
IE - Irlanda 1.278
VN - Vietnam 1.277
KR - Corea 1.122
SE - Svezia 1.058
DE - Germania 717
FR - Francia 496
FI - Finlandia 491
IN - India 443
GB - Regno Unito 366
UA - Ucraina 322
AU - Australia 198
ID - Indonesia 185
AR - Argentina 145
JO - Giordania 144
CA - Canada 143
TR - Turchia 126
JP - Giappone 106
BD - Bangladesh 97
NL - Olanda 96
IQ - Iraq 91
MX - Messico 89
ES - Italia 77
ZA - Sudafrica 67
AT - Austria 58
EC - Ecuador 57
CI - Costa d'Avorio 52
PK - Pakistan 51
NG - Nigeria 49
CO - Colombia 46
PH - Filippine 35
MA - Marocco 34
CH - Svizzera 33
SA - Arabia Saudita 31
BE - Belgio 30
UZ - Uzbekistan 29
AE - Emirati Arabi Uniti 25
GR - Grecia 25
PE - Perù 24
VE - Venezuela 24
BJ - Benin 23
CL - Cile 22
PY - Paraguay 21
KZ - Kazakistan 20
SC - Seychelles 20
KE - Kenya 19
LT - Lituania 18
AZ - Azerbaigian 17
EG - Egitto 17
KG - Kirghizistan 17
BG - Bulgaria 16
JM - Giamaica 16
TH - Thailandia 16
CZ - Repubblica Ceca 15
DZ - Algeria 15
UY - Uruguay 15
NP - Nepal 14
TN - Tunisia 14
IL - Israele 13
NZ - Nuova Zelanda 13
TW - Taiwan 12
OM - Oman 11
GE - Georgia 10
PA - Panama 10
AL - Albania 9
MY - Malesia 9
RS - Serbia 9
CR - Costa Rica 8
RO - Romania 8
LV - Lettonia 7
PT - Portogallo 7
SK - Slovacchia (Repubblica Slovacca) 7
BO - Bolivia 6
BY - Bielorussia 6
DO - Repubblica Dominicana 6
IR - Iran 6
LB - Libano 6
SY - Repubblica araba siriana 6
EE - Estonia 5
HU - Ungheria 5
NI - Nicaragua 5
SN - Senegal 5
TT - Trinidad e Tobago 5
DK - Danimarca 4
KH - Cambogia 4
MU - Mauritius 4
NO - Norvegia 4
SI - Slovenia 4
BA - Bosnia-Erzegovina 3
BH - Bahrain 3
ET - Etiopia 3
EU - Europa 3
HN - Honduras 3
Totale 57.100
Città #
Santa Clara 4.817
Ashburn 3.412
Singapore 2.764
Fairfield 2.323
Warsaw 2.253
Hong Kong 1.612
Chandler 1.287
Dublin 1.272
Seoul 1.109
Woodbridge 1.092
Seattle 1.009
Cambridge 929
Houston 894
Dallas 835
Wilmington 774
Hefei 743
Beijing 672
San Jose 670
Altamura 525
Jacksonville 505
Lawrence 486
Dearborn 451
Ho Chi Minh City 405
Ann Arbor 395
Los Angeles 366
Buffalo 364
Princeton 343
The Dalles 341
Lauterbourg 311
Council Bluffs 285
Hanoi 281
Florence 273
Moscow 266
Mumbai 247
Boston 218
Munich 218
Boardman 215
Melbourne 192
New York 192
Medford 168
San Diego 146
Helsinki 141
Kent 141
Jakarta 136
Shanghai 136
São Paulo 135
Bremen 119
Tokyo 93
Izmir 85
Orem 78
Clifton 75
Turku 74
Lappeenranta 69
Frankfurt am Main 68
Paris 65
Norwalk 64
London 61
Chicago 59
Guangzhou 58
Da Nang 55
Rome 55
Toronto 55
Milan 54
Abidjan 52
Rio de Janeiro 52
Montreal 51
Falls Church 49
Chennai 48
Abuja 47
Brooklyn 47
Redondo Beach 47
Haiphong 46
Nuremberg 45
Pune 42
Dong Ket 40
Phoenix 39
Bengaluru 38
Yubileyny 38
West Jordan 36
Denver 35
Johannesburg 35
Hillsboro 34
Stockholm 34
Belo Horizonte 32
Nanjing 31
Andover 30
Baghdad 30
Poplar 30
Brussels 29
Kunming 29
Manchester 29
Atlanta 28
Amsterdam 27
San Francisco 27
Tianjin 27
Jinan 26
Tashkent 26
Vienna 25
Brasília 24
Shenzhen 24
Totale 38.865
Nome #
Clinical and neuroimaging profiles to identify C9orf72-FTD patients and serum Neurofilament to monitor the progression and the severity of the disease 380
Low Florbetapir PET Uptake and Normal Aβ1-42 Cerebrospinal Fluid in an APP Ala713Thr Mutation Carrier 326
Increased susceptibility to amyloid toxicity in familial Alzheimer's fibroblasts 309
Lipid Rafts Mediate Amyloid-induced Calcium Dyshomeostasis and Oxidative Stress in Alzheimer's Disease. 307
Fat Mass and Obesity-Associated Gene (FTO) in Eating Disorders: Evidence for Association of the rs9939609 Obesity Risk Allele with Bulimia nervosa and Anorexia nervosa 301
Immunoproteasome LMP2 60HH variant alters MBP epitope generation and reduces the risk to develop multiple sclerosis in Italian female population. 297
Membrane cholesterol enrichment prevents Abeta-induced oxidative stress in Alzheimer's fibroblasts. 295
Association Study of Genetic Variants in CDKN2A/CDKN2B genes/Loci with Late-Onset Alzheimer's Disease 286
FDG PET and the genetics of dementia 282
Fat mass and obesity-associated gene (FTO) is associated to eating disorders susceptibility and moderates the expression of psychopathological traits 273
A Pilot Study Evaluating the Contribution of SLC19A1 (RFC-1) 80G>A Polymorphism to Alzheimer’s Disease in Italian Caucasians 268
Donor-specific anti-HLA antibodies in Huntington’s disease recipients of human fetal striatal grafts 265
Evidence for sub-haplogroup h5 of mitochondrial DNA as a risk factor for late onset Alzheimer's disease 262
A novel network analysis approach reveals DNA damage, oxidative stress and calcium/cAMP homeostasis-associated biomarkers in frontotemporal dementia 258
Specific Silencing of L392V PSEN1 Mutant Allele by RNA Interference 255
Analyses of the role of the glucocorticoid receptor gene polymorphism (rs41423247) as a potential moderator in the association between childhood overweight, psychopathology, and clinical outcomes in Eating Disorders patients: A 6 years follow up study. 244
Alzheimer's Disease Progression: Factors Influencing Cognitive Decline 244
Comparative effects on tumor induction and root differentiation in potato tuber disks of the physiological state and its modification by DMSO treatment and infection with mutant A. tumefaciens strains. 243
Gene-Wide Analysis Detects Two New Susceptibility Genes for Alzheimer's Disease 236
Tumor necrosis factor α influences phenotypic plasticity and promotes epigenetic changes in human basal forebrain cholinergic neuroblasts 229
5-HT2A receptor gene polymorphism and eating disorders. 223
Age at symptom onset and death and disease duration in genetic frontotemporal dementia: an international retrospective cohort study 220
A2 macroglobulin polymorphisms in Italian sporadic and familial Alzheimer’s disease 217
Immune-related genetic enrichment in frontotemporal dementia: An analysis of genome-wide association studies 214
Lipid rafts are primary mediators of amyloid oxidative attack on plasma membrane 213
Challenges in Alzheimer's Disease Diagnostic Work-Up: Amyloid Biomarker Incongruences 212
A family with spinocerebellar ataxia type 8 expansion and vitamin E deficiency ataxia. 210
Association analysis of the paraoxonase-1 gene with Alzheimer's disease 209
Association of the New Variant Tyr424Asp at TBK1 Gene with Amyotrophic Lateral Sclerosis and Cognitive Decline 208
Cognitive reserve and TMEM106B genotype modulate brain damage in presymptomatic frontotemporal dementia: a GENFI study 205
Ataxia-telangiectasia mutated (ATM) genetic variant in Italian centenarians 204
Alzheimer's Disease CSF Biomarker Profiles in Idiopathic Normal Pressure Hydrocephalus 203
Apathy in presymptomatic genetic frontotemporal dementia predicts cognitive decline and is driven by structural brain changes 202
Brain-derived neurotrophic factor, apolipoprotein E genetic variants and cognitive performance in Alzheimer's disease. 200
Association of the Variant Cys139Arg at GRN Gene to the Clinical Spectrum of Frontotemporal Lobar Degeneration 198
Anomia is present pre-symptomatically in frontotemporal dementia due to MAPT mutations 197
A case of atypical early-onset Alzheimer’s disease carrying the missense mutation Thr354Ile in exon 10 of the PSEN1 gene 197
Genome-wide association study identifies eight risk loci and implicates metabo-psychiatric origins for anorexia nervosa 196
5-HT2A receptor gene polymorphisms in anorexia nervosa and bulimia nervosa 195
The implication of BDNF Val66Met polymorphism in progression from subjective cognitive decline to mild cognitive impairment and Alzheimer's disease: a 9-year follow-up study 195
Association of IL10 promoter polymorphism in Italian Alzheimer's disease. 194
A presenilin-1 mutation (Leu392Pro) in a familial AD kindred with psychiatric symptoms at onset. 193
From Subjective Cognitive Decline to Alzheimer's Disease: The Predictive Role of Neuropsychological Assessment, Personality Traits, and Cognitive Reserve. A 7-Year Follow-Up Study 193
Dual Effect of PER2 C111G Polymorphism on Cognitive Functions across Progression from Subjective Cognitive Decline to Mild Cognitive Impairment 192
Progranulin plasma levels predict the presence of GRN mutations in asymptomatic subjects and do not correlate with brain atrophy: results from the GENFI study 192
A new social-family model for eating disorders: A European multicentre project using a case-control design 190
Combined family trio and case-control analysis of the COMT Val158Met polymorphism in European patients with anorexia nervosa. 190
Assessing the effectiveness of subjective cognitive decline plus criteria in predicting the progression to Alzheimer’s disease: an 11-year follow-up study 190
CAG Repeats Within the Non-pathological Range in the HTT Gene Influence Personality Traits in Patients With Subjective Cognitive Decline: A 13-Year Follow-Up Study 189
Association between serotonin transporter gene polymorphism and eating disorders outcome: A 6-year follow-up study. 189
Impact of demography and population dynamics on the genetic architecture of human longevity 189
Identification of new presenilin gene mutations in early-onset familial Alzheimer disease 188
A case of limbic encephalitis evolving into a frontotemporal dementia-like picture 187
5-HT2A promoter polymorphism in anorexia nervosa. 186
Potential genetic modifiers of disease risk and age at onset in patients with frontotemporal lobar degeneration and GRN mutations: a genome-wide association study 186
Brain functional network integrity sustains cognitive function despite atrophy in presymptomatic genetic frontotemporal dementia 185
A Pan-European study of theC9orf72Repeat Associated with FTLD: Geographic Prevalence, Genomic Instability and Intermediate Repeats 184
KIBRA T allele influences memory performance and progression of cognitive decline: a 7-year follow-up study in subjective cognitive decline and mild cognitive impairment 183
Biomarkers study in atypical dementia: proof of a diagnostic work-up 183
Cognitive composites for genetic frontotemporal dementia: GENFI-Cog 183
Deleterious ABCA7 mutations and transcript rescue mechanisms in early onset Alzheimer’s disease 181
MCI conversion to dementia and the APOE genotype: a prediction study with FDG-PET 180
Comparison of arterial spin labeling registration strategies in the multi-center GENetic frontotemporal dementia initiative (GENFI) 180
Autosomal Dominant Frontotemporal Lobar Degeneration Due to the C9ORF72 Hexanucleotide Repeat Expansion: Late-Onset Psychotic Clinical Presentation 180
Unravelling neural correlates of empathy deficits in Subjective Cognitive Decline, Mild Cognitive Impairment and Alzheimer's Disease 179
Cerebral perfusion changes in presymptomatic genetic frontotemporal dementia: a GENFI study 179
Analysis of brain atrophy and local gene expression in genetic frontotemporal dementia 179
Long-term use of pharmacological treatment in Alzheimer's disease: a retrospective cohort study in real-world clinical practice 179
Differences and Similarities in Empathy Deficit and Its Neural Basis between Logopenic and Amnesic Alzheimer's Disease 178
Implication of serotonin-transporter (5-HTT) gene polymorphism in subjective memory complaints and mild cognitive impairment (MCI). 178
Spatiotemporal analysis for detection of pre-symptomatic shape changes in neurodegenerative diseases: Initial application to the GENFI cohort 178
High Frequency of Crossed Aphasia in Dextral in an Italian Cohort of Patients with Logopenic Primary Progressive Aphasia 178
Fragile X premutation with atypical symptoms at onset. 177
Loss of speech and functional impairment in Alzheimer's disease-related primary progressive aphasia: predictive factors of decline 176
ApoE genotype and familial Alzheimer's disease: a possible influence on age of onset in APP717 Val-->Ile mutated families. 176
Predicting the functional outcome of intensive inpatient rehabilitation after stroke: results from the RIPS Study 175
No implication of apolipoprotein E polymorphism in Italian schizophrenic patients. 175
Genetics of vascular dementia - review from the ICVD working group 175
Plasma neurofilament light chain predicts Alzheimer's disease in patients with subjective cognitive decline and mild cognitive impairment: A cross-sectional and longitudinal study 174
Age and ApoE genotype interaction in Alzheimer's disease: an FDG-PET study 174
ApolipoproteinE epsilon 4 allele is not associated with disease course and severity in multiple sclerosis. 174
Pattern and progression of cognitive decline in Alzheimer's disease:role of premorbid intelligence and ApoE genotype 174
Intermediate alleles of HTT: A new pathway in longevity 173
Genetic and clinical analysis of spinocerebellar ataxia type 8 repeat expansion in Italy 173
A novel Alzheimer disease locus located near the gene encoding tau protein 173
Downregulation of exosomal miR-204-5p and miR-632 as a biomarker for FTD: a GENFI study 173
Novel S-acyl glutathione derivatives prevent amyloid oxidative stress and cholinergic dysfunction in Alzheimer disease models. Free Radic Biol Med. 173
Italian Frontotemporal Dementia Network (FTD Group-SINDEM): sharing clinical and diagnostic procedures in Frontotemporal Dementia in Italy 173
Alzheimer's disease: role of size and location of white matter changes in determining cognitive deficits. 172
Hypometabolism exceeds atrophy in presymptomatic early-onset familial Alzheimer's disease 171
Angiotensin converting enzyme insertion/deletion polymorphism in sporadic and familial Alzheimer's disease and longevity 171
Distinct patterns of brain atrophy in Genetic Frontotemporal Dementia Initiative (GENFI) cohort revealed by visual rating scales 171
A C6orf10/LOC101929163 locus is associated with age of onset in C9orf72 carriers 171
Influence of apoe genotype and clock t3111c interaction with cardiovascular risk factors on the progression to alzheimer’s disease in subjective cognitive decline and mild cognitive impairment patients 171
Codon 129 polymorphism of prion protein gene in sporadic Alzheimer's disease. 171
Data-driven staging of genetic frontotemporal dementia using multi-modal MRI 170
Temporal order of clinical and biomarker changes in familial frontotemporal dementia 170
Cathepsin D polymorphism in Italian sporadic and familial Alzheimer's disease. 170
Monomeric ß-amyloid interacts with type-1 insulin-like growth factor receptors to provide energy supply to neurons 170
Association of NTRK3 and its interaction with NGF suggest an altered cross-regulation of the neurotrophin signaling pathway in eating disorders. 170
Totale 20.429
Categoria #
all - tutte 164.222
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 164.222


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021803 0 0 0 0 0 0 0 0 0 413 177 213
2021/20222.236 55 161 209 72 78 106 102 190 118 89 387 669
2022/20235.947 597 1.343 206 556 382 1.037 775 278 551 34 133 55
2023/20242.505 111 219 371 130 167 234 111 720 56 144 173 69
2024/202515.887 533 1.794 1.079 2.418 4.186 2.014 222 929 826 494 623 769
2025/202617.999 2.132 2.801 2.367 1.770 2.417 835 2.279 995 1.247 1.156 0 0
Totale 57.605